Peripheral intervention drug-eluting devices include stents and balloons. Due to their non-invasive nature, peripheral intervention drug-eluting devices provide greater treatment efficiency, thus assisting in managing cardiovascular diseases over the period. The drug-eluting stent (DES) is peripheral or coronary is placed into narrowed, affected coronary or peripheral arteries that very slowly release a drug to inhibit cell proliferation. This prevents fibrosis that, together with clots, could otherwise block the stented artery, a restenosis process. On the other hand, the drug-eluting balloon catheter is an advanced medical device that has shown remarkable efficiency in carrying out the procedures. Multiple companies are now shifting towards the manufacturing of drug-eluting balloon catheters since they are proving to be much more effective as compared to stenting or balloon angioplasty. Also, a drug-eluting balloon catheter can help treat patients who do not benefit from percutaneous coronary intervention (PCI).
MARKET DYNAMICS
The peripheral intervention drug-eluting devices market has shown a significant evolution over the forecast period. The rise of the peripheral intervention drug-eluting devices market is majorly driven by the increasing number of patients with cardiovascular ailments and the surging rate of cardiology intervention procedures. According to the CDC (Centre for Disease Control), approximately 8.5 million people in the U.S. suffer from PAD (Peripheral Artery Disease), including 12-20% of individuals older than 60 years of age. This rising prevalence of peripheral artery diseases and increasing healthcare expenditure in lower-middle-income countries is expected to boost the growth of the global peripheral intervention drug-eluting devices market over the forecast period. Manufacturers are trying to develop low-cost devices, which will further expand its adoption over the next couple of years. Moreover, improved reimbursement support, increasing healthcare expenditure, and growing geriatric population are some of the other additional factors likely to influence the market's growth. However, the occurrence of stent thrombosis is expected to restrain the market growth.
MARKET SCOPE
The "Peripheral Intervention Drug-Eluting Devices Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry's medical device, with a specific focus on the global market trend analysis. This report provides an outline of the peripheral intervention drug-eluting devices market with detailed market segmentation by product, application, and end-user. The peripheral intervention drug-eluting devices market is estimated to witness high growth during the forecast period. It focuses on the vital statistics on the leading players' market status in the peripheral intervention drug-eluting devices market and offers key opportunities and trends in the market.
MARKET SEGMENTATION
The market is categorized based on the product, application, and end user. Based on the product, the market is segmented as drug-eluting balloons and drug-eluting stents. Based on the application, the segmentation of the market is into plain old balloon angioplasty (POBA) and percutaneous transluminal angioplasty (PTA). Based on end user, segmentation of the market is into hospitals, catheterization laboratories, ambulatory surgical centers, and others.
REGIONAL FRAMEWORK
The report states a detailed outline of the industry, consisting of both qualitative and quantitative information. It gives a sketch and forecast of the peripheral intervention drug-eluting devices market based on various segments. The report also consists of market size and forecast estimates from the year 2020 to2028with respect to five primary regions, namely; North America, Asia-Pacific (APAC), Europe, Middle East, and Africa (MEA), and South & Central America (SCAM). The peripheral intervention drug-eluting devices market by each region is then subdivided into respective countries and segments. It offers the analysis and forecast of 18 countries worldwide and the recent trend and opportunities prevailing in the region.
The report analyzes factors affecting the peripheral intervention drug-eluting devices market from both the demand and supply sides. Furthermore, it assesses market dynamics affecting the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also comprises a precise PEST analysis for all five regions, namely, North America, APAC, Europe, MEA, and South & Central America, after evaluating political, social, economic, and technological factors affecting the peripheral intervention drug-eluting devices market in these regions.
MARKET PLAYERS
The report contains critical developments in the peripheral intervention drug-eluting devices market as inorganic and organic growth strategies. Various companies are pivoting on organic growth strategies like product approvals, product launches, and others, such as events and patents. Inorganic growth strategies noticed in the market were acquisitions and collaborations &partnerships. Such activities have paved the path for the expansion of the business and customer base of market players. The market players from the peripheral intervention drug-eluting devices market are anticipated to have profitable growth opportunities in the following years with the increasing demand for peripheral intervention drug-eluting devices in the global market. Below mentioned is the list of a few companies engaged in the peripheral intervention drug-eluting devices market.
The report also offers key players' profiles in the peripheral intervention drug-eluting devices market, along with their SWOT analysis and market strategies. Also, the report focuses on leading market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.
- Abbott.
- BIOTRONIK SE & Co. KG
- Cook
- Cardinal Health. (Cordis)
- Boston Scientific Corporation
- C.R. Bard Inc.
- Medtronic
- Terumo Medical Corporation
- Meril Life Sciences Pvt. Ltd.
- B. Braun Melsungen AG
The Insight Partner's dedicated research and analysis team comprises of experienced professionals with advanced statistical expertise and offers various customization options in the current study.